VIRAX BIOLABS GROUP LTD
VRAXNASDAQ🏆 #4486 by market capEarnings Dec 2US Equity
$2.87▲ $0.01 (+0.35%)
🌅 Pre-market$2.88▲ 0.35%Regular close · extended-hours price shown1h—
24h▲ 0.3%
7d▼ 4.3%
14d▼ 3.7%
30d▼ 31.5%
1y▼ 85.5%
🏦Market Cap
$535,614
Small Cap
📈Revenue Growth (YoY)
+96.2%
High Growth
📊Gross Margin
-1480.5%
Thin
💵FCF Margin
-56607.7%
Thin
⚖️P/S Ratio
38.2x
Expensive
Otter Score
53
Weak
Earnings
Q3 · 2026Reported 2026-07-01Earnings Per Share
Actual
—
Expected
-1.75
—
—
Revenue
Actual
$10.82K
Expected
$1.31K
beat
+726.60%
Consensus estimates
Recent quarters
Q3 2026
—
—
Q4 2025
-12.25
miss
Q4 2025
-19.00
miss
Q4 2024
-22.25
—